Souvien Therapeutics

Souvien Therapeutics creates innovative drugs for neurodegenerative diseases by targeting the epigenetic basis of these conditions. Souvien Therapeutics, a private BVI company, was co-founded by Professor Li-Huei Tsai and Associate Professor Stephen Haggarty in collaboration with Juvenescence Ltd.